He must not have read your reply to my posting. LOL. Although he could still be correct if the entire confidence interval were on the wrong side of 0. The reversal of relative treatment effect from that observed in prior trials for both drugs is mind boggling. This is yet another prime example of cross-trial comparison and why FDA has resisted Bayesian analysis in drug trials.
Market Data 
Markets 
AI
